Literature DB >> 24816633

A cross-sectional analysis of otitis media with effusion in children with Down syndrome.

M Maris1, M Wojciechowski, P Van de Heyning, An Boudewyns.   

Abstract

UNLABELLED: Children with Down syndrome are at risk to develop otitis media with effusion (OME). We performed a retrospective and cross-sectional analysis to evaluate the prevalence of OME in children with Down syndrome (DS) for consecutive age categories between 6 months and 12 years. Clinical and audiometric data were available for 107 children followed in a multidisciplinary Down team. A high prevalence of OME was found at the age of 1 year (66.7 %), with a second peak prevalence of 60 % at 6-7 years. A declining trend was observed in children ≥8 years. Overall, 52.3 % of DS children had either OME or ventilation tubes at the time of evaluation. Hearing thresholds were significantly higher in children with bilateral OME (median 36.7 decibel hearing level (dB HL), range 26.7-46.1) compared to those with at least one normally ventilated middle ear (median 28.3 dB HL, range 22.8-3.3), p = 0.013.
CONCLUSION: We found a high prevalence of OME in children with Down syndrome, with a peak of ≥60 % around 1 and 6-7 years. A declining trend is seen in older children. Mild to moderate hearing loss was present in children with bilateral OME.

Entities:  

Mesh:

Year:  2014        PMID: 24816633     DOI: 10.1007/s00431-014-2323-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  Hearing loss in Down's syndrome. A treatable handicap more common than generally recognized.

Authors:  T J Balkany; M P Downs; B W Jafek; M J Krajicek
Journal:  Clin Pediatr (Phila)       Date:  1979-02       Impact factor: 1.168

2.  Identification of hearing loss in pediatric patients with Down syndrome.

Authors:  Albert H Park; Matt A Wilson; Paul T Stevens; Richard Harward; Nancy Hohler
Journal:  Otolaryngol Head Neck Surg       Date:  2011-10-10       Impact factor: 3.497

3.  Clinical experience with impedance audiometry.

Authors:  J Jerger
Journal:  Arch Otolaryngol       Date:  1970-10

Review 4.  Down syndrome: common otolaryngologic manifestations.

Authors:  Sally R Shott
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-08-15       Impact factor: 3.908

5.  Down's syndrome: a modern otorhinolaryngological perspective.

Authors:  M Strome
Journal:  Laryngoscope       Date:  1981-10       Impact factor: 3.325

6.  Health supervision for children with Down syndrome.

Authors:  Marilyn J Bull
Journal:  Pediatrics       Date:  2011-07-25       Impact factor: 7.124

Review 7.  Diagnosis of pediatric cholesteatoma.

Authors:  Glenn Isaacson
Journal:  Pediatrics       Date:  2007-09       Impact factor: 7.124

8.  Hearing loss in children with Down syndrome.

Authors:  N J Roizen; C Wolters; T Nicol; T A Blondis
Journal:  J Pediatr       Date:  1993-07       Impact factor: 4.406

Review 9.  The otolaryngologist's approach to the patient with Down syndrome.

Authors:  Regina Rodman; Harold S Pine
Journal:  Otolaryngol Clin North Am       Date:  2012-06       Impact factor: 3.346

10.  Hearing loss in Chinese school children with Down syndrome.

Authors:  Bradley McPherson; Sandy Pui-Shan Lai; Kevin Kwong-Ki Leung; Iris Hoi-Yee Ng
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2007-10-23       Impact factor: 1.675

View more
  7 in total

1.  Prevalence of Cholesteatoma in Children With Down Syndrome Receiving Treatment at Pediatric Health Care Facilities.

Authors:  Alycia Spinner; Ajit Munjuluru; Christopher T Wootten
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-09-01       Impact factor: 6.223

Review 2.  Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.

Authors:  Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

Review 3.  Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches.

Authors:  Clíona Farrell; Paige Mumford; Frances K Wiseman
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

Review 4.  Otitis media with effusion and atopy: is there a causal relationship?

Authors:  Mario E Zernotti; Ruby Pawankar; Ignacio Ansotegui; Hector Badellino; Juan Sebastian Croce; Elham Hossny; Motohiro Ebisawa; Nelson Rosario; Mario Sanchez Borges; Yuan Zhang; Luo Zhang
Journal:  World Allergy Organ J       Date:  2017-11-14       Impact factor: 4.084

5.  Altered Toll-Like Receptor Signalling in Children with Down Syndrome.

Authors:  Dean Huggard; W J Koay; Lynne Kelly; Fiona McGrane; Emer Ryan; Niamh Lagan; Edna Roche; Joanne Balfe; T Ronan Leahy; Orla Franklin; Ana Moreno-Oliveira; Ashanty M Melo; Derek G Doherty; Eleanor J Molloy
Journal:  Mediators Inflamm       Date:  2019-09-12       Impact factor: 4.711

6.  Comprehensive phenotypic analysis of the Dp1Tyb mouse strain reveals a broad range of Down syndrome-related phenotypes.

Authors:  Eva Lana-Elola; Heather Cater; Sheona Watson-Scales; Simon Greenaway; Jennifer Müller-Winkler; Dorota Gibbins; Mihaela Nemes; Amy Slender; Tertius Hough; Piia Keskivali-Bond; Cheryl L Scudamore; Eleanor Herbert; Gareth T Banks; Helene Mobbs; Tara Canonica; Justin Tosh; Suzanna Noy; Miriam Llorian; Patrick M Nolan; Julian L Griffin; Mark Good; Michelle Simon; Ann-Marie Mallon; Sara Wells; Elizabeth M C Fisher; Victor L J Tybulewicz
Journal:  Dis Model Mech       Date:  2021-10-15       Impact factor: 5.732

7.  Health comorbidities and cognitive abilities across the lifespan in Down syndrome.

Authors:  Carla M Startin; Hana D'Souza; George Ball; Sarah Hamburg; Rosalyn Hithersay; Kate M O Hughes; Esha Massand; Annette Karmiloff-Smith; Michael S C Thomas; Andre Strydom
Journal:  J Neurodev Disord       Date:  2020-01-23       Impact factor: 4.025

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.